VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HCSG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HCSGHealthcare Services Group, Inc.
$24.50$1.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHCSGCash Flow

Healthcare Services Group, Inc. (HCSG) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash generation remains inconsistent, evidenced by an OCF/NI ratio that fluctuated from a negative 9.13 in 2024Q2 to a positive 3.04 in 2024Q4, complicating long-term capital deployment strategies.

HCSG Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations161.2M144.97M30.8M43.5M-8.17M37.11M217.21M93.58M80.03M7.63M41.4M63.36M57.73M32.16M60.38M32.95M37.75M38.31M16.66M25.77M16.12M24.5M19.43M16.74M16.11M12.5M7.75M1.6M3.3M5.4M8.9M
Operating CF Margin %-7.89%1.8%2.6%-0.48%2.26%12.34%5.08%3.98%0.41%2.65%4.41%4.46%2.8%5.6%3.71%4.88%5.53%2.76%4.46%3.15%5.25%4.39%4.41%4.91%4.4%3.04%0.69%1.61%2.98%5.48%
Operating CF Growth %1636.8%370.64%-29.19%632.61%-122.01%-82.92%132.11%16.93%948.9%-81.57%-34.66%9.75%79.52%-46.74%83.25%-12.71%-1.46%129.91%-35.35%59.87%-34.19%26.04%16.08%3.91%28.95%61.22%384.41%-51.52%-38.89%-39.33%50.85%
Net Income67.89M59.06M39.47M38.39M34.63M45.86M98.68M64.58M83.52M88.23M77.4M58.02M21.85M47.13M44.21M38.16M34.44M30.34M26.61M29.58M25.45M19.1M14.7M10.86M8.63M7.04M5.59M5.5M8.9M5.9M6.9M
Depreciation & Amortization16.75M17.07M14.59M14.34M15.32M14.67M14.27M13.94M9.27M8.89M7.5M7.66M7.27M6.2M5.12M4.39M3.76M3.23M2.85M3M2.31M1.87M1.87M1.91M2.03M2.24M2.21M2.1M2.1M2.1M2.2M
Stock-Based Compensation11.03M12.01M9.16M8.98M9.21M8.83M7.87M6.87M5.9M276K4.25M3.54M3.08M2.61M2.54M2.15M1.33M1.07M563K291M481M0000000000
Deferred Taxes21.28M19.2M-2.94M-4.82M5.05M3.07M-5.89M-684K-13.01M1.89M20K15.97M-15.06M-4.92M-3.49M275K517K-2.39M1.18M-759K-1.39M-399K-986K-174.4K-1.29M-1.48M200.8K0-800K300K700K
Other Non-Cash Items81.21M78.18M40.72M30.77M42.4M7.83M3.4M19.66M54.19M3.04M4.89M5.04M3.61M-293K1.02M4.04M2.8M1.06M5.65M-284.99M-480.87M4.21M5.26M5.17M6.73M5.74M3.25M7.3M-100K-100K-100K
Working Capital Changes-36.97M-40.55M-70.19M-44.16M-114.77M-43.15M98.88M-10.78M-59.84M-94.68M-52.66M-26.87M36.98M-18.57M10.98M-16.06M-5.11M4.99M-20.2M-12.06M-10.38M-283K-1.42M-1.03M7.47K-1.04M-3.5M-13.3M-9.7M-3.8M-2.9M
Change in Receivables-12.18M5.23M-61.81M-74.56M-78.71M-37.19M38.08M-29.53M-44.36M-121.64M-61.05M-18.85M-13.49M-50.88M-11.63M1.06B0-1.93B67.8M1.96B764.85M0000000000
Change in Inventory1.38M-48K1.73M2.69M4.85M5.6M4.93M4.76M950K-1.87M-1.49M-846K-3.02M-3.77M-3.53M-4.53M-3.64M-620K-963K-2.48M-840K-714K-560K-1.79M-681.53K439.76K196.22K-800K-500K100K-200K
Change in Payables-2.06M-12.06M-9.74M7.43M-13.75M10.24M-7.25M-9.53M-9.14M11.2M-4.25M2.4M492K25.96M13.66M-1.08B01.93B-85M-2.13B-774M0000000000
Cash from Investing-8.08M-11M6.05M-3.29M2.58M-22.99M-36.84M-16.46M-9.59M-14.97M-6.45M-62.31M-6.46M605K5.69M4.51M3.08M-10.23M-49.86M-1.85M-11.44M-1.81M-2.07M-2.09M-1.71M-1.74M-1.36M-1.8M-2.4M-1.5M-2.1M
Capital Expenditures-5.47M-5.82M-6.34M-5.41M-5.21M-5.69M-4.34M-4.37M-4.94M-5.4M-5.44M-5M-5.79M-3.76M-3.48M-5.54M-4.17M-2.15M-1.58M-1.5M-1.85M-1.9M-2.39M-2.31M-1.86M-2.05M-1.8M-2.9M-2.8M-1.8M-2.4M
CapEx % of Revenue0.3%0.32%0.37%0.32%0.31%0.35%0.25%0.24%0.25%0.29%0.35%0.35%0.45%0.33%0.32%0.62%0.54%0.31%0.26%0.26%0.36%0.41%0.54%0.61%0.57%0.72%0.71%1.25%1.37%0.99%1.48%
Acquisitions249K-7.15M-2.75M0-114K-23.88M0199K640K-4.58M275K267K0-5M0-1M0-4.61M0-477K-9.74M0000000000
Investments-------------------------------
Other Investing-4.56M105K211K121K393K211K274K0640K338K275K267K83K158K26K22K44K2K157K132K151K85K321K221.03K152.11K313.21K439.85K1.1M400K300K300K
Cash from Financing-81.23M-63.33M-31.05M-12.15M-38.93M-82.65M-68.37M-75.82M-53.98M-6.96M-44.28M-43.14M-40.15M-37.56M-35.75M-38.52M-32.44M-34.27M-21.76M-4.46M-22.69M-6.53M-6.7M1.21M-343.21K659.99K-743.57K200K-1.5M-8.7M-400K
Debt Issued (Net)00-25M025M0-10M-20M-5.38M35.38M0000000-4.72M00-6.16M0000000000
Equity Issued (Net)-77.07M-61.59M-5.02M-11.28M106K-21.44M93K3.72M89K95K109K113K110K107K118K128K121K88K-4.65M5.46M-5.15M1.55M-2.1M2.69M-343K659.99K-743.57K200K-1.5M-8.7M-400K
Dividends Paid0000-63.37M-62.23M-60.7M-58.95M-57.2M-55.24M-53.34M-51.38M-49.08M-46.71M-44.09M-42.23M-39.28M-32.25M-24.98M-17.74M-12.63M-8.08M-4.6M-1.49M0000000
Share Repurchases-78.51M-61.59M-5.02M-11.28M0-21.54M000000000000-4.65M0-8.49M-4.03M-6.03M-164K-2.13M-824.94K-761.88K-200K-3.5M-10.9M-500K
Other Financing-4.16M-1.74M-1.03M-871K-661K1.01M2.25M-587K8.52M12.81M8.95M8.12M8.82M9.04M8.22M3.58M6.73M2.6M7.88M7.82M1.25M001.02K0000000
Net Change in Cash71.89M70.64M5.8M28.05M-44.52M-68.54M112M1.3M16.47M-14.3M-9.34M-42.09M11.13M-4.79M30.31M-1.05M8.39M-6.2M-54.96M19.46M-18.01M16.16M10.67M15.86M14.06M11.42M5.64M0-1.5M-8.7M-400K
Free Cash Flow155.72M139.15M24.47M38.09M-13.38M31.42M212.87M89.21M75.09M2.23M35.96M58.36M51.94M28.4M56.89M27.4M33.57M36.15M15.09M24.27M14.27M22.6M17.05M14.43M14.25M10.44M5.95M-1.3M500K3.6M6.5M
FCF Margin %8.41%7.57%1.43%2.28%-0.79%1.91%12.09%4.85%3.74%0.12%2.3%4.06%4.02%2.47%5.28%3.08%4.34%5.22%2.5%4.2%2.79%4.85%3.85%3.8%4.34%3.68%2.34%-0.56%0.24%1.98%4%
FCF Growth %98.49%468.75%-35.77%384.76%-142.57%-85.24%138.61%18.81%3262.79%-93.79%-38.39%12.38%82.9%-50.09%107.61%-18.38%-7.14%139.66%-37.83%70.1%-36.87%32.56%18.11%1.27%36.45%75.64%557.44%-360%-86.11%-44.62%103.13%
FCF per Share2.191.910.330.51-0.180.422.851.201.010.030.490.800.730.410.830.410.500.540.230.370.220.350.270.240.240.190.11-0.020.010.060.11
FCF Conversion (FCF/Net Income)2.29x2.45x0.78x1.13x-0.24x0.76x2.20x1.45x0.96x0.09x0.53x1.09x2.64x0.68x1.37x0.86x1.10x1.26x0.63x0.87x0.63x1.28x1.32x1.54x1.87x1.78x1.39x0.29x0.37x0.92x1.29x
Interest Paid1.68M06.49M7.81M2.82M1.39M1.37M3.46M3.09M1.36M574K258K156K4K3K2K000000000000000
Taxes Paid0015.23M5.58M3.31M21.23M44.87M20.03M37.68M35.37M32.53M7.9M25.08M21.69M24.68M14.61M000000000000000

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Client credit and labor volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Divergence

Based on reported financial data, HCSG exhibits significant volatility in its cash conversion, with the OCF/NI ratio swinging from a negative 9.13 in 2024Q2 to a positive 3.04 in 2024Q4, indicating that net income is a poor proxy for the company's actual cash-generating capacity.

The frequent divergence between net income and operating cash flow suggests that non-cash items and accrual adjustments, likely related to bad debt provisions and insurance reserves, heavily distort reported earnings. Investors should view the company's bottom-line profitability with caution, as the cash flow statement reveals a much more erratic operational reality than the income statement implies.

FCF Volatility Limits Capital Flexibility

As reported in quarterly filings, HCSG's free cash flow margins have fluctuated wildly, ranging from a negative 6.7% in 2024Q1 to a peak of 15.1% in 2025Q3, demonstrating that the company's ability to generate sustainable excess cash is highly sensitive to operational and client-side disruptions.

This inconsistency in free cash flow generation complicates the company's ability to maintain a predictable capital allocation strategy. The sharp swings suggest that the business model lacks the operational leverage required to smooth out cash flow during periods of increased client credit risk or rising labor costs.

Working Capital Swings Signal Risk

According to the cash flow statements, working capital changes have been a major source of volatility, with a $50 million outflow in 2024Q1 followed by a $21.6 million inflow in 2023Q4, highlighting the company's vulnerability to the payment cycles of its skilled nursing facility client base.

These dramatic shifts in working capital suggest that HCSG is frequently acting as a de facto lender to its clients by absorbing delayed payments. The reliance on these fluctuations to manage liquidity warrants close monitoring, as persistent working capital outflows may indicate deteriorating credit quality among the firm's primary service recipients.

Aggressive Buybacks Amidst Cash Uncertainty

Based on recent financial statements, HCSG has prioritized share repurchases, utilizing $24 million in 2026Q1 alone, despite the underlying volatility in operating cash flow, which suggests a management preference for returning capital to shareholders even when operational cash generation remains inconsistent and unpredictable.

The decision to aggressively buy back shares while operating cash flow remains erratic may limit the company's financial buffer against future regulatory or labor-related shocks. This capital allocation strategy appears to prioritize short-term equity support over the preservation of liquidity, which could prove problematic if client solvency issues intensify.

HCSG — Frequently Asked Questions

Quick answers to the most common questions about buying HCSG stock.

How much cash does Healthcare Services Group, Inc. (HCSG) generate from operations?

Healthcare Services Group, Inc. (HCSG) generated $145.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Healthcare Services Group, Inc.'s free cash flow?

Healthcare Services Group, Inc. (HCSG) generated $139.2M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Healthcare Services Group, Inc.'s capital expenditure (CapEx)?

Healthcare Services Group, Inc. (HCSG) spent $5.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Healthcare Services Group, Inc. distribute cash to shareholders?

In 2025, Healthcare Services Group, Inc. (HCSG) spent $61.6M on share repurchases. This shows the company's commitment to returning capital to its equity investors.